BridgeMD
New treatment option for Hematologic Malignancies
Official title DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
ClinicalTrials.gov ID: NCT06296368
What this study is testing
- What it's testing
- The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
- Written or verbal informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
- people are willing and able to comply with study procedures based on the judgment of the investigator.
- Age ≥ 60 years at the time of consent.
- New patient to either the hematologic malignancies clinic or the bone marrow transplant/cellular therapy clinic.
You likely can't join if
- All people meeting any of the exclusion criteria listed below at baseline will be excluded from study participation:
- 1\. Dementia, altered mental status, or psychiatric condition that would prohibit the understanding or rendering of informed consent or participation...
The study team makes the final eligibility decision.
Where it's taking place
- Chapel Hill, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chapel Hill, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.